{
    "info": {
        "nct_id": "NCT02948283",
        "official_title": "A Pilot Feasibility Study of Metformin/Ritonavir Combination Treatment in Patients With Relapsed/Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia",
        "inclusion_criteria": "* All subjects must have the ability to understand and the willingness to sign a written informed consent\n* Life expectancy of > 3 months\n* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2\n\nFOR PATIENTS WITH MULTIPLE MYELOMA (MM):\n\n* Diagnosis of multiple myeloma\n* Patients with MM must have measurable disease, defined as one or more of the following:\n\n  * Serum M-protein >= 0.5 g/dL\n  * Urine M-protein >= 200 mg/24 hr\n  * Serum immunoglobulin free light chain (FLC) >= 100 mg/L (10 mg/dL) and abnormal serum immunoglobulin kappa to lambda FLC ratio\n\n    * IgA patients must have serum quantitative immunoglobulin >= 750 mg/dL\n    * Patients with oligosecretory or non-secretory disease must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range\n* Disease must be refractory or relapsed after >= 3 prior regimens (induction therapy and stem cell transplant +/- maintenance will be considered as one regimen)\n\nFOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL):\n\n* Diagnosis of CLL without the following: Richter's transformation, prolymphocytic leukemia (PLL), small lymphocytic lymphoma (SLL)\n* Measurable disease, defined as one or more of the following:\n\n  * Lymphocytosis >= 5000 in peripheral blood\n  * Measurable lymph nodes > 1.5 cm on palpation and/or computed tomography (CT) scan\n  * Organomegaly by physical exam and/or CT scan\n* Active disease per International Workshop on Chronic Lymphocytic (IWCLL) 2008 criteria, as defined as one of the following:\n\n  * Evidence of progressive marrow failure as manifested by the development of, or worsening of, anemia and/or thrombocytopenia\n  * Massive (i.e., at least 6 cm below the left costal margin) or progressive or symptomatic splenomegaly\n  * Massive nodes (i.e., at least 10 cm in longest diameter) or progressive or symptomatic lymphadenopathy\n  * Progressive lymphocytosis with an increase of more than 50 percent over a two-month period or lymphocyte doubling time (LDT) of less than six months; LDT can be obtained by linear regression extrapolation of absolute lymphocyte counts obtained at intervals of two weeks over an observation period of two to three months; in patients with initial blood lymphocyte counts of less than 30 x 10^9/L (30,000/L), LDT should not be used as a single parameter to define a treatment indication; in addition, factors contributing to lymphocytosis or lymphadenopathy other than CLL (e.g., infection) should be excluded\n  * Autoimmune anemia and/or thrombocytopenia that is poorly responsive to corticosteroids or other standard therapy\n  * Constitutional symptoms, defined as any one or more of the following disease-related symptoms or signs:\n\n    * Unintentional weight loss of 10 percent or more within the previous six months\n    * Significant fatigue (i.e., ECOG performance scale [PS] 2 or worse; inability to work or perform usual activities)\n    * Fevers higher than 100.5 degrees Fahrenheit (F) or 38.0 degrees Celsius (C) for two or more weeks without other evidence of infection\n    * Night sweats for more than one month without evidence of infection\n* Received at least 2 prior therapies (regimens) for CLL\n* In the opinion of the investigator do not require rapid cytoreduction due to bulky disease (e.g. painful lymphadenopathy or organomegaly, or impending end-organ dysfunction\n* Absolute neutrophil count (ANC) >= 1,000/mm^3\n* Platelets >= 50,000/mm^3\n* Aspartate aminotransferase (AST) =< 3 x upper limit of normal (ULN)\n* Alanine aminotransferase (ALT) =< 3 x ULN\n* Total bilirubin =< 1.5 x ULN; unless presence of Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment\n* Creatinine clearance of >= 45 mL/min per 24 hour urine collection or the Cockcroft-Gault formula\n* Woman of childbearing potential (WOCBP): negative urine or serum pregnancy test; if the urine test is positive or cannot be confirmed as negative, a serum pregnancy test will be required\n* Corrected QT interval (QTc) =< 480 msec per Fridericia's formula AND PR interval =< 200 msec (using 12-lead electrocardiography [EKG])\n* Agreement by woman of childbearing potential and sexually active males to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation\n\n  * A woman of childbearing potential is defined as a sexually mature woman who:\n\n    * Has not undergone a hysterectomy or bilateral oophorectomy; or\n    * Has not been naturally postmenopausal for at least 24 consecutive months\n\nFOR PATIENTS WITH MM OR CLL:\n\n- At least 2 weeks from prior therapy to time of start of treatment; prior therapy includes steroids (except for =< 10 mg daily prednisone or equivalent which is permitted during the study)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Current or planned use of other investigational agents, or concurrent biological, chemotherapy, or radiation therapy during the study treatment period\n* Use of a protease inhibitor for any indication within three months prior to start of study treatment\n* Current or planned use of prohibited meds\n* Liver disease, except Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment\n* Current pancreatitis\n* History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients\n* Non-hematologic malignancy within the past 3 years aside from the following exceptions:\n\n  * Adequately treated basal cell or squamous cell skin cancer\n  * Carcinoma in situ of the cervix\n  * Prostate cancer < Gleason grade 6 with a stable prostate-specific antigen test (PSA)\n  * Successfully treated in situ carcinoma of the breast\n* Clinically significant cardiac disease, including:\n\n  * >= Grade 2 myocardial infarction within 6 months prior to day 1 of protocol therapy\n  * Unstable or uncontrolled disease condition relating to or affecting cardiac function (e.g. unstable angina, congestive heart failure, New York Heart Association Class III-IV) within 6 months prior to day 1 of protocol therapy\n  * >= Grade 2 uncontrolled cardiac arrhythmia\n* Clinically significant medical disease or condition that, in the investigator's opinion, may interfere with protocol adherence or the patient's ability to give informed consent\n* Women who are currently or planning to breastfeed during protocol treatment\n* Any other condition that would, in the investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns or compliance with clinical study procedures, e.g., infection/inflammation, intestinal obstruction, unable to swallow medication, social/ psychological issues, uncontrolled intercurrent illness etc.\n* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "identified_line": {
                "line": "* Constitutional symptoms, defined as any one or more of the following disease-related symptoms or signs:",
                "criterions": [
                    {
                        "exact_snippets": "Constitutional symptoms, defined as any one or more of the following disease-related symptoms or signs",
                        "criterion": "constitutional symptoms",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Constitutional symptoms, defined as any one or more of the following disease-related symptoms or signs",
                        "criterion": "constitutional symptoms",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Alanine aminotransferase (ALT) =< 3 x ULN",
                "criterions": [
                    {
                        "exact_snippets": "Alanine aminotransferase (ALT) =< 3 x ULN",
                        "criterion": "alanine aminotransferase (ALT) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Alanine aminotransferase (ALT) =< 3 x ULN",
                        "criterion": "alanine aminotransferase (ALT) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x ULN"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Must have minimum age of 18 Years",
                "criterions": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "minimum age of 18 Years",
                        "criterion": "age",
                        "requirement": {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* All subjects must have the ability to understand and the willingness to sign a written informed consent",
                "criterions": [
                    {
                        "exact_snippets": "ability to understand",
                        "criterion": "cognitive ability",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "willingness to sign a written informed consent",
                        "criterion": "willingness to provide informed consent",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "ability to understand",
                        "criterion": "cognitive ability",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "willingness to sign a written informed consent",
                        "criterion": "willingness to provide informed consent",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Platelets >= 50,000/mm^3",
                "criterions": [
                    {
                        "exact_snippets": "Platelets >= 50,000/mm^3",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50000,
                                "unit": "mm^3"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Platelets >= 50,000/mm^3",
                        "criterion": "platelet count",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 50000,
                                "unit": "mm^3"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Lymphocytosis >= 5000 in peripheral blood",
                "criterions": [
                    {
                        "exact_snippets": "Lymphocytosis >= 5000 in peripheral blood",
                        "criterion": "lymphocytosis in peripheral blood",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 5000,
                                "unit": ""
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Lymphocytosis >= 5000 in peripheral blood",
                        "criterion": "lymphocytosis in peripheral blood",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 5000,
                                "unit": ""
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Life expectancy of > 3 months",
                "criterions": [
                    {
                        "exact_snippets": "Life expectancy of > 3 months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Life expectancy of > 3 months",
                        "criterion": "life expectancy",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 3,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Measurable disease, defined as one or more of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Measurable disease",
                        "criterion": "disease",
                        "requirement": {
                            "requirement_type": "measurability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Measurable disease",
                        "criterion": "disease",
                        "requirement": {
                            "requirement_type": "measurability",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Patients with MM must have measurable disease, defined as one or more of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Patients with MM must have measurable disease",
                        "criterion": "measurable disease in multiple myeloma (MM)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Patients with MM must have measurable disease",
                        "criterion": "measurable disease in multiple myeloma (MM)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL):",
                "criterions": [
                    {
                        "exact_snippets": "FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)",
                        "criterion": "chronic lymphocytic leukemia (CLL) diagnosis",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "FOR PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)",
                        "criterion": "chronic lymphocytic leukemia (CLL) diagnosis",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Diagnosis of CLL without the following: Richter's transformation, prolymphocytic leukemia (PLL), small lymphocytic lymphoma (SLL)",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of CLL",
                        "criterion": "chronic lymphocytic leukemia (CLL) diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "without the following: Richter's transformation",
                        "criterion": "Richter's transformation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "without the following: ... prolymphocytic leukemia (PLL)",
                        "criterion": "prolymphocytic leukemia (PLL)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "without the following: ... small lymphocytic lymphoma (SLL)",
                        "criterion": "small lymphocytic lymphoma (SLL)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Diagnosis of CLL",
                        "criterion": "chronic lymphocytic leukemia (CLL) diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "without the following: Richter's transformation",
                        "criterion": "Richter's transformation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "without the following: ... prolymphocytic leukemia (PLL)",
                        "criterion": "prolymphocytic leukemia (PLL)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "without the following: ... small lymphocytic lymphoma (SLL)",
                        "criterion": "small lymphocytic lymphoma (SLL)",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* A woman of childbearing potential is defined as a sexually mature woman who:",
                "criterions": [
                    {
                        "exact_snippets": "woman of childbearing potential",
                        "criterion": "childbearing potential",
                        "requirement": {
                            "requirement_type": "sexually mature",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "woman of childbearing potential",
                        "criterion": "childbearing potential",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "woman of childbearing potential",
                        "criterion": "childbearing potential",
                        "requirement": {
                            "requirement_type": "sexually mature",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "woman of childbearing potential",
                        "criterion": "childbearing potential",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Eastern Cooperative Oncology Group (ECOG) performance status of 0-2",
                "criterions": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Eastern Cooperative Oncology Group (ECOG) performance status of 0-2",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 0,
                                        "unit": "N/A"
                                    },
                                    {
                                        "operator": "<=",
                                        "value": 2,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Fevers higher than 100.5 degrees Fahrenheit (F) or 38.0 degrees Celsius (C) for two or more weeks without other evidence of infection",
                "criterions": [
                    {
                        "exact_snippets": "Fevers higher than 100.5 degrees Fahrenheit (F) or 38.0 degrees Celsius (C) for two or more weeks",
                        "criterion": "fever",
                        "requirement": {
                            "requirement_type": "temperature",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">",
                                        "value": 100.5,
                                        "unit": "degrees Fahrenheit"
                                    },
                                    {
                                        "operator": ">",
                                        "value": 38.0,
                                        "unit": "degrees Celsius"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "Fevers higher than 100.5 degrees Fahrenheit (F) or 38.0 degrees Celsius (C) for two or more weeks",
                        "criterion": "fever",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without other evidence of infection",
                        "criterion": "evidence of infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "or_criteria": [
                                    {
                                        "exact_snippets": "Fevers higher than 100.5 degrees Fahrenheit (F) or 38.0 degrees Celsius (C) for two or more weeks",
                                        "criterion": "fever",
                                        "requirement": {
                                            "requirement_type": "temperature",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": ">",
                                                        "value": 100.5,
                                                        "unit": "degrees Fahrenheit"
                                                    },
                                                    {
                                                        "operator": ">",
                                                        "value": 38.0,
                                                        "unit": "degrees Celsius"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "exact_snippets": "Fevers higher than 100.5 degrees Fahrenheit (F) or 38.0 degrees Celsius (C) for two or more weeks",
                                "criterion": "fever",
                                "requirement": {
                                    "requirement_type": "duration",
                                    "expected_value": {
                                        "operator": ">=",
                                        "value": 2,
                                        "unit": "weeks"
                                    }
                                }
                            }
                        ]
                    },
                    {
                        "exact_snippets": "without other evidence of infection",
                        "criterion": "evidence of infection",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Corrected QT interval (QTc) =< 480 msec per Fridericia's formula AND PR interval =< 200 msec (using 12-lead electrocardiography [EKG])",
                "criterions": [
                    {
                        "exact_snippets": "Corrected QT interval (QTc) =< 480 msec per Fridericia's formula",
                        "criterion": "corrected QT interval (QTc)",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 480,
                                "unit": "msec"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Corrected QT interval (QTc) =< 480 msec per Fridericia's formula",
                        "criterion": "corrected QT interval (QTc)",
                        "requirement": {
                            "requirement_type": "correction_formula",
                            "expected_value": "Fridericia's formula"
                        }
                    },
                    {
                        "exact_snippets": "PR interval =< 200 msec (using 12-lead electrocardiography [EKG])",
                        "criterion": "PR interval",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": "<=",
                                "value": 200,
                                "unit": "msec"
                            }
                        }
                    },
                    {
                        "exact_snippets": "PR interval =< 200 msec (using 12-lead electrocardiography [EKG])",
                        "criterion": "PR interval",
                        "requirement": {
                            "requirement_type": "measurement_method",
                            "expected_value": "12-lead electrocardiography (EKG)"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Corrected QT interval (QTc) =< 480 msec per Fridericia's formula",
                                "criterion": "corrected QT interval (QTc)",
                                "requirement": {
                                    "requirement_type": "duration",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 480,
                                        "unit": "msec"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "Corrected QT interval (QTc) =< 480 msec per Fridericia's formula",
                                "criterion": "corrected QT interval (QTc)",
                                "requirement": {
                                    "requirement_type": "correction_formula",
                                    "expected_value": "Fridericia's formula"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "PR interval =< 200 msec (using 12-lead electrocardiography [EKG])",
                                "criterion": "PR interval",
                                "requirement": {
                                    "requirement_type": "duration",
                                    "expected_value": {
                                        "operator": "<=",
                                        "value": 200,
                                        "unit": "msec"
                                    }
                                }
                            },
                            {
                                "exact_snippets": "PR interval =< 200 msec (using 12-lead electrocardiography [EKG])",
                                "criterion": "PR interval",
                                "requirement": {
                                    "requirement_type": "measurement_method",
                                    "expected_value": "12-lead electrocardiography (EKG)"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Progressive lymphocytosis with an increase of more than 50 percent over a two-month period or lymphocyte doubling time (LDT) of less than six months; LDT can be obtained by linear regression extrapolation of absolute lymphocyte counts obtained at intervals of two weeks over an observation period of two to three months; in patients with initial blood lymphocyte counts of less than 30 x 10^9/L (30,000/L), LDT should not be used as a single parameter to define a treatment indication; in addition, factors contributing to lymphocytosis or lymphadenopathy other than CLL (e.g., infection) should be excluded",
                "criterions": [
                    {
                        "exact_snippets": "Progressive lymphocytosis with an increase of more than 50 percent over a two-month period",
                        "criterion": "lymphocytosis",
                        "requirement": {
                            "requirement_type": "progression",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Progressive lymphocytosis with an increase of more than 50 percent over a two-month period",
                        "criterion": "lymphocytosis",
                        "requirement": {
                            "requirement_type": "increase",
                            "expected_value": {
                                "operator": ">",
                                "value": 50,
                                "unit": "percent"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Progressive lymphocytosis with an increase of more than 50 percent over a two-month period",
                        "criterion": "lymphocytosis",
                        "requirement": {
                            "requirement_type": "time_period",
                            "expected_value": {
                                "operator": "=",
                                "value": 2,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "lymphocyte doubling time (LDT) of less than six months",
                        "criterion": "lymphocyte doubling time (LDT)",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    },
                    {
                        "exact_snippets": "in patients with initial blood lymphocyte counts of less than 30 x 10^9/L (30,000/L), LDT should not be used as a single parameter to define a treatment indication",
                        "criterion": "initial blood lymphocyte count",
                        "requirement": {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 30,
                                "unit": "x 10^9/L"
                            }
                        }
                    },
                    {
                        "exact_snippets": "in patients with initial blood lymphocyte counts of less than 30 x 10^9/L (30,000/L), LDT should not be used as a single parameter to define a treatment indication",
                        "criterion": "initial blood lymphocyte count",
                        "requirement": {
                            "requirement_type": "LDT as single parameter for treatment indication",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "factors contributing to lymphocytosis or lymphadenopathy other than CLL (e.g., infection) should be excluded",
                        "criterion": "factors contributing to lymphocytosis or lymphadenopathy other than CLL",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Progressive lymphocytosis with an increase of more than 50 percent over a two-month period",
                                        "criterion": "lymphocytosis",
                                        "requirement": {
                                            "requirement_type": "progression",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "Progressive lymphocytosis with an increase of more than 50 percent over a two-month period",
                                        "criterion": "lymphocytosis",
                                        "requirement": {
                                            "requirement_type": "increase",
                                            "expected_value": {
                                                "operator": ">",
                                                "value": 50,
                                                "unit": "percent"
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "Progressive lymphocytosis with an increase of more than 50 percent over a two-month period",
                                        "criterion": "lymphocytosis",
                                        "requirement": {
                                            "requirement_type": "time_period",
                                            "expected_value": {
                                                "operator": "=",
                                                "value": 2,
                                                "unit": "months"
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "factors contributing to lymphocytosis or lymphadenopathy other than CLL (e.g., infection) should be excluded",
                                        "criterion": "factors contributing to lymphocytosis or lymphadenopathy other than CLL",
                                        "requirement": {
                                            "requirement_type": "presence",
                                            "expected_value": false
                                        }
                                    }
                                ]
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "lymphocyte doubling time (LDT) of less than six months",
                                        "criterion": "lymphocyte doubling time (LDT)",
                                        "requirement": {
                                            "requirement_type": "value",
                                            "expected_value": {
                                                "operator": "<",
                                                "value": 6,
                                                "unit": "months"
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "factors contributing to lymphocytosis or lymphadenopathy other than CLL (e.g., infection) should be excluded",
                                        "criterion": "factors contributing to lymphocytosis or lymphadenopathy other than CLL",
                                        "requirement": {
                                            "requirement_type": "presence",
                                            "expected_value": false
                                        }
                                    },
                                    {
                                        "or_criteria": [
                                            {
                                                "not_criteria": {
                                                    "not_criteria": {
                                                        "exact_snippets": "in patients with initial blood lymphocyte counts of less than 30 x 10^9/L (30,000/L), LDT should not be used as a single parameter to define a treatment indication",
                                                        "criterion": "initial blood lymphocyte count",
                                                        "requirement": {
                                                            "requirement_type": "value",
                                                            "expected_value": {
                                                                "operator": "<",
                                                                "value": 30,
                                                                "unit": "x 10^9/L"
                                                            }
                                                        }
                                                    }
                                                }
                                            },
                                            {
                                                "and_criteria": [
                                                    {
                                                        "exact_snippets": "in patients with initial blood lymphocyte counts of less than 30 x 10^9/L (30,000/L), LDT should not be used as a single parameter to define a treatment indication",
                                                        "criterion": "initial blood lymphocyte count",
                                                        "requirement": {
                                                            "requirement_type": "value",
                                                            "expected_value": {
                                                                "operator": "<",
                                                                "value": 30,
                                                                "unit": "x 10^9/L"
                                                            }
                                                        }
                                                    },
                                                    {
                                                        "exact_snippets": "in patients with initial blood lymphocyte counts of less than 30 x 10^9/L (30,000/L), LDT should not be used as a single parameter to define a treatment indication",
                                                        "criterion": "initial blood lymphocyte count",
                                                        "requirement": {
                                                            "requirement_type": "LDT as single parameter for treatment indication",
                                                            "expected_value": false
                                                        }
                                                    }
                                                ]
                                            }
                                        ]
                                    }
                                ]
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "Healthy volunteers allowed",
                "criterions": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Healthy volunteers allowed",
                        "criterion": "healthy volunteer status",
                        "requirement": {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Urine M-protein >= 200 mg/24 hr",
                "criterions": [
                    {
                        "exact_snippets": "Urine M-protein >= 200 mg/24 hr",
                        "criterion": "urine M-protein",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 200,
                                "unit": "mg/24 hr"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Urine M-protein >= 200 mg/24 hr",
                        "criterion": "urine M-protein",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 200,
                                "unit": "mg/24 hr"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Active disease per International Workshop on Chronic Lymphocytic (IWCLL) 2008 criteria, as defined as one of the following:",
                "criterions": [
                    {
                        "exact_snippets": "Active disease per International Workshop on Chronic Lymphocytic (IWCLL) 2008 criteria",
                        "criterion": "chronic lymphocytic leukemia (CLL) disease activity",
                        "requirement": {
                            "requirement_type": "activity status",
                            "expected_value": "active per IWCLL 2008 criteria"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Active disease per International Workshop on Chronic Lymphocytic (IWCLL) 2008 criteria",
                        "criterion": "chronic lymphocytic leukemia (CLL) disease activity",
                        "requirement": {
                            "requirement_type": "activity status",
                            "expected_value": "active per IWCLL 2008 criteria"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Unintentional weight loss of 10 percent or more within the previous six months",
                "criterions": [
                    {
                        "exact_snippets": "Unintentional weight loss of 10 percent or more within the previous six months",
                        "criterion": "unintentional weight loss",
                        "requirement": {
                            "requirement_type": "amount",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "percent"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Unintentional weight loss of 10 percent or more within the previous six months",
                        "criterion": "unintentional weight loss",
                        "requirement": {
                            "requirement_type": "timeframe",
                            "expected_value": "within the previous six months"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Unintentional weight loss of 10 percent or more within the previous six months",
                        "criterion": "unintentional weight loss",
                        "requirement": {
                            "requirement_type": "amount",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "percent"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Unintentional weight loss of 10 percent or more within the previous six months",
                        "criterion": "unintentional weight loss",
                        "requirement": {
                            "requirement_type": "timeframe",
                            "expected_value": "within the previous six months"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* In the opinion of the investigator do not require rapid cytoreduction due to bulky disease (e.g. painful lymphadenopathy or organomegaly, or impending end-organ dysfunction",
                "criterions": [
                    {
                        "exact_snippets": "do not require rapid cytoreduction due to bulky disease",
                        "criterion": "requirement for rapid cytoreduction",
                        "requirement": {
                            "requirement_type": "necessity",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "bulky disease (e.g. painful lymphadenopathy or organomegaly, or impending end-organ dysfunction",
                        "criterion": "bulky disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "painful lymphadenopathy",
                        "criterion": "painful lymphadenopathy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "organomegaly",
                        "criterion": "organomegaly",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "impending end-organ dysfunction",
                        "criterion": "impending end-organ dysfunction",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "do not require rapid cytoreduction due to bulky disease",
                        "criterion": "requirement for rapid cytoreduction",
                        "requirement": {
                            "requirement_type": "necessity",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "bulky disease (e.g. painful lymphadenopathy or organomegaly, or impending end-organ dysfunction",
                        "criterion": "bulky disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "painful lymphadenopathy",
                        "criterion": "painful lymphadenopathy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "organomegaly",
                        "criterion": "organomegaly",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "impending end-organ dysfunction",
                        "criterion": "impending end-organ dysfunction",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Significant fatigue (i.e., ECOG performance scale [PS] 2 or worse; inability to work or perform usual activities)",
                "criterions": [
                    {
                        "exact_snippets": "Significant fatigue",
                        "criterion": "fatigue",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    },
                    {
                        "exact_snippets": "ECOG performance scale [PS] 2 or worse",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "inability to work or perform usual activities",
                        "criterion": "ability to work or perform usual activities",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Significant fatigue",
                        "criterion": "fatigue",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "significant"
                        }
                    },
                    {
                        "exact_snippets": "ECOG performance scale [PS] 2 or worse",
                        "criterion": "ECOG performance status",
                        "requirement": {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": "inability to work or perform usual activities",
                        "criterion": "ability to work or perform usual activities",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Has not undergone a hysterectomy or bilateral oophorectomy; or",
                "criterions": [
                    {
                        "exact_snippets": "Has not undergone a hysterectomy",
                        "criterion": "hysterectomy",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Has not undergone ... bilateral oophorectomy",
                        "criterion": "bilateral oophorectomy",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Has not undergone a hysterectomy",
                        "criterion": "hysterectomy",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Has not undergone ... bilateral oophorectomy",
                        "criterion": "bilateral oophorectomy",
                        "requirement": {
                            "requirement_type": "history of procedure",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Patients with oligosecretory or non-secretory disease must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                "criterions": [
                    {
                        "exact_snippets": "Patients with oligosecretory or non-secretory disease",
                        "criterion": "oligosecretory or non-secretory disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                        "criterion": "free light chain ratio",
                        "requirement": {
                            "requirement_type": "abnormality",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                        "criterion": "free light chain ratio",
                        "requirement": {
                            "requirement_type": "range",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<",
                                        "value": 0.26,
                                        "unit": ""
                                    },
                                    {
                                        "operator": ">",
                                        "value": 1.65,
                                        "unit": ""
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                        "criterion": "free light chain ratio",
                        "requirement": {
                            "requirement_type": "beyond laboratory calculation range",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "condition": {
                    "exact_snippets": "Patients with oligosecretory or non-secretory disease",
                    "criterion": "oligosecretory or non-secretory disease",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                },
                "then_criteria": {
                    "or_criteria": [
                        {
                            "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                            "criterion": "free light chain ratio",
                            "requirement": {
                                "requirement_type": "abnormality",
                                "expected_value": true
                            }
                        },
                        {
                            "or_criteria": [
                                {
                                    "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                                    "criterion": "free light chain ratio",
                                    "requirement": {
                                        "requirement_type": "range",
                                        "expected_value": {
                                            "comparisons": [
                                                {
                                                    "operator": "<",
                                                    "value": 0.26,
                                                    "unit": ""
                                                },
                                                {
                                                    "operator": ">",
                                                    "value": 1.65,
                                                    "unit": ""
                                                }
                                            ]
                                        }
                                    }
                                },
                                {
                                    "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                                    "criterion": "free light chain ratio",
                                    "requirement": {
                                        "requirement_type": "beyond laboratory calculation range",
                                        "expected_value": true
                                    }
                                }
                            ]
                        },
                        {
                            "or_criteria": [
                                {
                                    "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                                    "criterion": "free light chain ratio",
                                    "requirement": {
                                        "requirement_type": "abnormality",
                                        "expected_value": true
                                    }
                                },
                                {
                                    "exact_snippets": "must have a documented abnormal free light chain ratio (normal value 0.26 to 1.65) or a value beyond the laboratory calculation range",
                                    "criterion": "free light chain ratio",
                                    "requirement": {
                                        "requirement_type": "beyond laboratory calculation range",
                                        "expected_value": true
                                    }
                                }
                            ]
                        }
                    ]
                },
                "else_criteria": null
            }
        },
        {
            "identified_line": {
                "line": "* Absolute neutrophil count (ANC) >= 1,000/mm^3",
                "criterions": [
                    {
                        "exact_snippets": "Absolute neutrophil count (ANC) >= 1,000/mm^3",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "mm^3"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Absolute neutrophil count (ANC) >= 1,000/mm^3",
                        "criterion": "absolute neutrophil count (ANC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1000,
                                "unit": "mm^3"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Night sweats for more than one month without evidence of infection",
                "criterions": [
                    {
                        "exact_snippets": "Night sweats for more than one month",
                        "criterion": "night sweats",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without evidence of infection",
                        "criterion": "infection",
                        "requirement": {
                            "requirement_type": "evidence",
                            "expected_value": false
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Night sweats for more than one month",
                        "criterion": "night sweats",
                        "requirement": {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">",
                                "value": 1,
                                "unit": "month"
                            }
                        }
                    },
                    {
                        "exact_snippets": "without evidence of infection",
                        "criterion": "infection",
                        "requirement": {
                            "requirement_type": "evidence",
                            "expected_value": false
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Evidence of progressive marrow failure as manifested by the development of, or worsening of, anemia and/or thrombocytopenia",
                "criterions": [
                    {
                        "exact_snippets": "Evidence of progressive marrow failure",
                        "criterion": "progressive marrow failure",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "development of, or worsening of, anemia",
                        "criterion": "anemia",
                        "requirement": {
                            "requirement_type": "development or worsening",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "development of, or worsening of, ... thrombocytopenia",
                        "criterion": "thrombocytopenia",
                        "requirement": {
                            "requirement_type": "development or worsening",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Evidence of progressive marrow failure",
                        "criterion": "progressive marrow failure",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "or_criteria": [
                            {
                                "exact_snippets": "development of, or worsening of, anemia",
                                "criterion": "anemia",
                                "requirement": {
                                    "requirement_type": "development or worsening",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "development of, or worsening of, ... thrombocytopenia",
                                "criterion": "thrombocytopenia",
                                "requirement": {
                                    "requirement_type": "development or worsening",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Diagnosis of multiple myeloma",
                "criterions": [
                    {
                        "exact_snippets": "Diagnosis of multiple myeloma",
                        "criterion": "multiple myeloma",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Diagnosis of multiple myeloma",
                        "criterion": "multiple myeloma",
                        "requirement": {
                            "requirement_type": "diagnosis",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Woman of childbearing potential (WOCBP): negative urine or serum pregnancy test; if the urine test is positive or cannot be confirmed as negative, a serum pregnancy test will be required",
                "criterions": [
                    {
                        "exact_snippets": "Woman of childbearing potential (WOCBP)",
                        "criterion": "sex and reproductive status",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "Woman of childbearing potential (WOCBP)",
                        "criterion": "sex and reproductive status",
                        "requirement": {
                            "requirement_type": "reproductive status",
                            "expected_value": "of childbearing potential"
                        }
                    },
                    {
                        "exact_snippets": "negative urine or serum pregnancy test",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "pregnancy test result",
                            "expected_value": "negative"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Woman of childbearing potential (WOCBP)",
                        "criterion": "sex and reproductive status",
                        "requirement": {
                            "requirement_type": "sex",
                            "expected_value": "female"
                        }
                    },
                    {
                        "exact_snippets": "Woman of childbearing potential (WOCBP)",
                        "criterion": "sex and reproductive status",
                        "requirement": {
                            "requirement_type": "reproductive status",
                            "expected_value": "of childbearing potential"
                        }
                    },
                    {
                        "exact_snippets": "negative urine or serum pregnancy test",
                        "criterion": "pregnancy status",
                        "requirement": {
                            "requirement_type": "pregnancy test result",
                            "expected_value": "negative"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Autoimmune anemia and/or thrombocytopenia that is poorly responsive to corticosteroids or other standard therapy",
                "criterions": [
                    {
                        "exact_snippets": "Autoimmune anemia and/or thrombocytopenia",
                        "criterion": "autoimmune anemia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Autoimmune anemia and/or thrombocytopenia",
                        "criterion": "autoimmune thrombocytopenia",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "poorly responsive to corticosteroids or other standard therapy",
                        "criterion": "autoimmune anemia or thrombocytopenia responsiveness to corticosteroids or other standard therapy",
                        "requirement": {
                            "requirement_type": "responsiveness",
                            "expected_value": "poorly responsive"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Autoimmune anemia and/or thrombocytopenia",
                                "criterion": "autoimmune anemia",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "poorly responsive to corticosteroids or other standard therapy",
                                "criterion": "autoimmune anemia or thrombocytopenia responsiveness to corticosteroids or other standard therapy",
                                "requirement": {
                                    "requirement_type": "responsiveness",
                                    "expected_value": "poorly responsive"
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Autoimmune anemia and/or thrombocytopenia",
                                "criterion": "autoimmune thrombocytopenia",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "poorly responsive to corticosteroids or other standard therapy",
                                "criterion": "autoimmune anemia or thrombocytopenia responsiveness to corticosteroids or other standard therapy",
                                "requirement": {
                                    "requirement_type": "responsiveness",
                                    "expected_value": "poorly responsive"
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Received at least 2 prior therapies (regimens) for CLL",
                "criterions": [
                    {
                        "exact_snippets": "Received at least 2 prior therapies (regimens) for CLL",
                        "criterion": "prior therapies for CLL",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "regimens"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Received at least 2 prior therapies (regimens) for CLL",
                        "criterion": "prior therapies for CLL",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "regimens"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Serum immunoglobulin free light chain (FLC) >= 100 mg/L (10 mg/dL) and abnormal serum immunoglobulin kappa to lambda FLC ratio",
                "criterions": [
                    {
                        "exact_snippets": "Serum immunoglobulin free light chain (FLC) >= 100 mg/L (10 mg/dL)",
                        "criterion": "serum immunoglobulin free light chain (FLC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100,
                                "unit": "mg/L"
                            }
                        }
                    },
                    {
                        "exact_snippets": "abnormal serum immunoglobulin kappa to lambda FLC ratio",
                        "criterion": "serum immunoglobulin kappa to lambda FLC ratio",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "abnormal"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Serum immunoglobulin free light chain (FLC) >= 100 mg/L (10 mg/dL)",
                        "criterion": "serum immunoglobulin free light chain (FLC)",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 100,
                                "unit": "mg/L"
                            }
                        }
                    },
                    {
                        "exact_snippets": "abnormal serum immunoglobulin kappa to lambda FLC ratio",
                        "criterion": "serum immunoglobulin kappa to lambda FLC ratio",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": "abnormal"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Massive nodes (i.e., at least 10 cm in longest diameter) or progressive or symptomatic lymphadenopathy",
                "criterions": [
                    {
                        "exact_snippets": "Massive nodes (i.e., at least 10 cm in longest diameter)",
                        "criterion": "lymph node size",
                        "requirement": {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "cm"
                            }
                        }
                    },
                    {
                        "exact_snippets": "progressive ... lymphadenopathy",
                        "criterion": "lymphadenopathy progression",
                        "requirement": {
                            "requirement_type": "progression",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "symptomatic lymphadenopathy",
                        "criterion": "lymphadenopathy symptoms",
                        "requirement": {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Massive nodes (i.e., at least 10 cm in longest diameter)",
                        "criterion": "lymph node size",
                        "requirement": {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 10,
                                "unit": "cm"
                            }
                        }
                    },
                    {
                        "exact_snippets": "progressive ... lymphadenopathy",
                        "criterion": "lymphadenopathy progression",
                        "requirement": {
                            "requirement_type": "progression",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "symptomatic lymphadenopathy",
                        "criterion": "lymphadenopathy symptoms",
                        "requirement": {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Has not been naturally postmenopausal for at least 24 consecutive months",
                "criterions": [
                    {
                        "exact_snippets": "Has not been naturally postmenopausal for at least 24 consecutive months",
                        "criterion": "menopausal status",
                        "requirement": {
                            "requirement_type": "postmenopausal duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 24,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Has not been naturally postmenopausal for at least 24 consecutive months",
                        "criterion": "menopausal status",
                        "requirement": {
                            "requirement_type": "postmenopausal duration",
                            "expected_value": {
                                "operator": "<",
                                "value": 24,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Aspartate aminotransferase (AST) =< 3 x upper limit of normal (ULN)",
                "criterions": [
                    {
                        "exact_snippets": "Aspartate aminotransferase (AST) =< 3 x upper limit of normal (ULN)",
                        "criterion": "aspartate aminotransferase (AST) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x upper limit of normal (ULN)"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Aspartate aminotransferase (AST) =< 3 x upper limit of normal (ULN)",
                        "criterion": "aspartate aminotransferase (AST) level",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "x upper limit of normal (ULN)"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "FOR PATIENTS WITH MULTIPLE MYELOMA (MM):",
                "criterions": [
                    {
                        "exact_snippets": "FOR PATIENTS WITH MULTIPLE MYELOMA (MM)",
                        "criterion": "multiple myeloma diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "FOR PATIENTS WITH MULTIPLE MYELOMA (MM)",
                        "criterion": "multiple myeloma diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Serum M-protein >= 0.5 g/dL",
                "criterions": [
                    {
                        "exact_snippets": "Serum M-protein >= 0.5 g/dL",
                        "criterion": "serum M-protein",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0.5,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Serum M-protein >= 0.5 g/dL",
                        "criterion": "serum M-protein",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 0.5,
                                "unit": "g/dL"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* IgA patients must have serum quantitative immunoglobulin >= 750 mg/dL",
                "criterions": [
                    {
                        "exact_snippets": "IgA patients must have serum quantitative immunoglobulin >= 750 mg/dL",
                        "criterion": "serum quantitative immunoglobulin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 750,
                                "unit": "mg/dL"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "IgA patients must have serum quantitative immunoglobulin >= 750 mg/dL",
                        "criterion": "serum quantitative immunoglobulin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 750,
                                "unit": "mg/dL"
                            }
                        }
                    }
                ]
            }
        }
    ],
    "exclusion_lines": [
        {
            "identified_line": {
                "line": "* Adequately treated basal cell or squamous cell skin cancer",
                "criterions": [
                    {
                        "exact_snippets": "Adequately treated basal cell or squamous cell skin cancer",
                        "criterion": "basal cell or squamous cell skin cancer",
                        "requirement": {
                            "requirement_type": "treatment status",
                            "expected_value": "adequately treated"
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Adequately treated basal cell or squamous cell skin cancer",
                    "criterion": "basal cell or squamous cell skin cancer",
                    "requirement": {
                        "requirement_type": "treatment status",
                        "expected_value": "adequately treated"
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "* Any other condition that would, in the investigator's judgment, contraindicate the patient's participation in the clinical study due to safety concerns or compliance with clinical study procedures, e.g., infection/inflammation, intestinal obstruction, unable to swallow medication, social/ psychological issues, uncontrolled intercurrent illness etc.",
                "criterions": [
                    {
                        "exact_snippets": "infection/inflammation",
                        "criterion": "infection or inflammation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "intestinal obstruction",
                        "criterion": "intestinal obstruction",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unable to swallow medication",
                        "criterion": "ability to swallow medication",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "social/ psychological issues",
                        "criterion": "social or psychological issues",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "uncontrolled intercurrent illness",
                        "criterion": "uncontrolled intercurrent illness",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "infection/inflammation",
                        "criterion": "infection or inflammation",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "intestinal obstruction",
                        "criterion": "intestinal obstruction",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unable to swallow medication",
                        "criterion": "ability to swallow medication",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "social/ psychological issues",
                        "criterion": "social or psychological issues",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "uncontrolled intercurrent illness",
                        "criterion": "uncontrolled intercurrent illness",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Women who are currently or planning to breastfeed during protocol treatment",
                "criterions": [
                    {
                        "exact_snippets": "Women who are currently ... breastfeed during protocol treatment",
                        "criterion": "breastfeeding status",
                        "requirement": {
                            "requirement_type": "current breastfeeding",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Women who are ... planning to breastfeed during protocol treatment",
                        "criterion": "breastfeeding intention during protocol treatment",
                        "requirement": {
                            "requirement_type": "intention to breastfeed during protocol treatment",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Women who are currently ... breastfeed during protocol treatment",
                        "criterion": "breastfeeding status",
                        "requirement": {
                            "requirement_type": "current breastfeeding",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Women who are ... planning to breastfeed during protocol treatment",
                        "criterion": "breastfeeding intention during protocol treatment",
                        "requirement": {
                            "requirement_type": "intention to breastfeed during protocol treatment",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Prostate cancer < Gleason grade 6 with a stable prostate-specific antigen test (PSA)",
                "criterions": [
                    {
                        "exact_snippets": "Prostate cancer < Gleason grade 6",
                        "criterion": "prostate cancer Gleason grade",
                        "requirement": {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": "<",
                                "value": 6,
                                "unit": ""
                            }
                        }
                    },
                    {
                        "exact_snippets": "stable prostate-specific antigen test (PSA)",
                        "criterion": "prostate-specific antigen test (PSA)",
                        "requirement": {
                            "requirement_type": "stability",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Prostate cancer < Gleason grade 6",
                                "criterion": "prostate cancer Gleason grade",
                                "requirement": {
                                    "requirement_type": "grade",
                                    "expected_value": {
                                        "operator": "<",
                                        "value": 6,
                                        "unit": ""
                                    }
                                }
                            },
                            {
                                "exact_snippets": "stable prostate-specific antigen test (PSA)",
                                "criterion": "prostate-specific antigen test (PSA)",
                                "requirement": {
                                    "requirement_type": "stability",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Current or planned use of other investigational agents, or concurrent biological, chemotherapy, or radiation therapy during the study treatment period",
                "criterions": [
                    {
                        "exact_snippets": "Current or planned use of other investigational agents",
                        "criterion": "use of other investigational agents",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "concurrent biological ... therapy during the study treatment period",
                        "criterion": "concurrent biological therapy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "concurrent ... chemotherapy ... during the study treatment period",
                        "criterion": "concurrent chemotherapy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "concurrent ... radiation therapy during the study treatment period",
                        "criterion": "concurrent radiation therapy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Current or planned use of other investigational agents",
                        "criterion": "use of other investigational agents",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "concurrent biological ... therapy during the study treatment period",
                        "criterion": "concurrent biological therapy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "concurrent ... chemotherapy ... during the study treatment period",
                        "criterion": "concurrent chemotherapy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "concurrent ... radiation therapy during the study treatment period",
                        "criterion": "concurrent radiation therapy",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Non-hematologic malignancy within the past 3 years aside from the following exceptions:",
                "criterions": [
                    {
                        "exact_snippets": "Non-hematologic malignancy within the past 3 years",
                        "criterion": "non-hematologic malignancy",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Non-hematologic malignancy within the past 3 years",
                        "criterion": "non-hematologic malignancy",
                        "requirement": {
                            "requirement_type": "history_within_timeframe",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 3,
                                        "unit": "years"
                                    }
                                ]
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* >= Grade 2 uncontrolled cardiac arrhythmia",
                "criterions": [
                    {
                        "exact_snippets": ">= Grade 2 uncontrolled cardiac arrhythmia",
                        "criterion": "cardiac arrhythmia",
                        "requirement": {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": ">= Grade 2 uncontrolled cardiac arrhythmia",
                        "criterion": "cardiac arrhythmia",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": ">= Grade 2 uncontrolled cardiac arrhythmia",
                        "criterion": "cardiac arrhythmia",
                        "requirement": {
                            "requirement_type": "grade",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    },
                    {
                        "exact_snippets": ">= Grade 2 uncontrolled cardiac arrhythmia",
                        "criterion": "cardiac arrhythmia",
                        "requirement": {
                            "requirement_type": "control status",
                            "expected_value": "uncontrolled"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients",
                "criterions": [
                    {
                        "exact_snippets": "History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients",
                        "criterion": "allergic reactions or hypersensitivity to compounds similar to metformin, ritonavir, or their ingredients",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients",
                        "criterion": "allergic reactions or hypersensitivity to compounds similar to metformin, ritonavir, or their ingredients",
                        "requirement": {
                            "requirement_type": "attribution",
                            "expected_value": "compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients",
                        "criterion": "allergic reactions or hypersensitivity to compounds similar to metformin, ritonavir, or their ingredients",
                        "requirement": {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "History of allergic reactions or hypersensitivity attributed to compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients",
                        "criterion": "allergic reactions or hypersensitivity to compounds similar to metformin, ritonavir, or their ingredients",
                        "requirement": {
                            "requirement_type": "attribution",
                            "expected_value": "compounds of similar chemical or biologic composition to metformin, ritonavir or any of their ingredients"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Prospective participants who, in the opinion of the investigator, may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
                "criterions": [
                    {
                        "exact_snippets": "may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
                        "criterion": "ability to comply with study procedures",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the opinion of the investigator",
                        "criterion": "investigator's opinion of participant's compliance",
                        "requirement": {
                            "requirement_type": "investigator assessment",
                            "expected_value": "participant is able to comply"
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "may not be able to comply with all study procedures (including compliance issues related to feasibility/logistics)",
                        "criterion": "ability to comply with study procedures",
                        "requirement": {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the opinion of the investigator",
                        "criterion": "investigator's opinion of participant's compliance",
                        "requirement": {
                            "requirement_type": "investigator assessment",
                            "expected_value": "participant is able to comply"
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Use of a protease inhibitor for any indication within three months prior to start of study treatment",
                "criterions": [
                    {
                        "exact_snippets": "Use of a protease inhibitor for any indication within three months prior to start of study treatment",
                        "criterion": "protease inhibitor use",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Use of a protease inhibitor for any indication within three months prior to start of study treatment",
                        "criterion": "protease inhibitor use",
                        "requirement": {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months prior to start of study treatment"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Use of a protease inhibitor for any indication within three months prior to start of study treatment",
                        "criterion": "protease inhibitor use",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Use of a protease inhibitor for any indication within three months prior to start of study treatment",
                        "criterion": "protease inhibitor use",
                        "requirement": {
                            "requirement_type": "time frame",
                            "expected_value": {
                                "operator": "<=",
                                "value": 3,
                                "unit": "months prior to start of study treatment"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Successfully treated in situ carcinoma of the breast",
                "criterions": [
                    {
                        "exact_snippets": "Successfully treated in situ carcinoma of the breast",
                        "criterion": "in situ carcinoma of the breast",
                        "requirement": {
                            "requirement_type": "treatment status",
                            "expected_value": "successfully treated"
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Successfully treated in situ carcinoma of the breast",
                    "criterion": "in situ carcinoma of the breast",
                    "requirement": {
                        "requirement_type": "treatment status",
                        "expected_value": "successfully treated"
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "* Clinically significant cardiac disease, including:",
                "criterions": [
                    {
                        "exact_snippets": "Clinically significant cardiac disease",
                        "criterion": "cardiac disease",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Clinically significant cardiac disease",
                        "criterion": "cardiac disease",
                        "requirement": {
                            "requirement_type": "clinical significance",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Current pancreatitis",
                "criterions": [
                    {
                        "exact_snippets": "Current pancreatitis",
                        "criterion": "pancreatitis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Current pancreatitis",
                        "criterion": "pancreatitis",
                        "requirement": {
                            "requirement_type": "current_status",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": "Current pancreatitis",
                        "criterion": "pancreatitis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Current pancreatitis",
                        "criterion": "pancreatitis",
                        "requirement": {
                            "requirement_type": "current_status",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Carcinoma in situ of the cervix",
                "criterions": [
                    {
                        "exact_snippets": "Carcinoma in situ of the cervix",
                        "criterion": "carcinoma in situ of the cervix",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "not_criteria": {
                    "exact_snippets": "Carcinoma in situ of the cervix",
                    "criterion": "carcinoma in situ of the cervix",
                    "requirement": {
                        "requirement_type": "presence",
                        "expected_value": true
                    }
                }
            }
        },
        {
            "identified_line": {
                "line": "* Current or planned use of prohibited meds",
                "criterions": [
                    {
                        "exact_snippets": "Current or planned use of prohibited meds",
                        "criterion": "use of prohibited medications",
                        "requirement": {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Current or planned use of prohibited meds",
                        "criterion": "use of prohibited medications",
                        "requirement": {
                            "requirement_type": "planned use",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Current or planned use of prohibited meds",
                        "criterion": "use of prohibited medications",
                        "requirement": {
                            "requirement_type": "current use",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Current or planned use of prohibited meds",
                        "criterion": "use of prohibited medications",
                        "requirement": {
                            "requirement_type": "planned use",
                            "expected_value": true
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* >= Grade 2 myocardial infarction within 6 months prior to day 1 of protocol therapy",
                "criterions": [
                    {
                        "exact_snippets": ">= Grade 2 myocardial infarction within 6 months prior to day 1 of protocol therapy",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "grade"
                            }
                        }
                    },
                    {
                        "exact_snippets": ">= Grade 2 myocardial infarction within 6 months prior to day 1 of protocol therapy",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "exact_snippets": ">= Grade 2 myocardial infarction within 6 months prior to day 1 of protocol therapy",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "grade"
                            }
                        }
                    },
                    {
                        "exact_snippets": ">= Grade 2 myocardial infarction within 6 months prior to day 1 of protocol therapy",
                        "criterion": "myocardial infarction",
                        "requirement": {
                            "requirement_type": "time since event",
                            "expected_value": {
                                "operator": "<=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Unstable or uncontrolled disease condition relating to or affecting cardiac function (e.g. unstable angina, congestive heart failure, New York Heart Association Class III-IV) within 6 months prior to day 1 of protocol therapy",
                "criterions": [
                    {
                        "exact_snippets": "Unstable or uncontrolled disease condition relating to or affecting cardiac function",
                        "criterion": "cardiac disease condition",
                        "requirement": {
                            "requirement_type": "stability",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Unstable or uncontrolled disease condition relating to or affecting cardiac function",
                        "criterion": "cardiac disease condition",
                        "requirement": {
                            "requirement_type": "control",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "unstable angina",
                        "criterion": "unstable angina",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "congestive heart failure",
                        "criterion": "congestive heart failure",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "New York Heart Association Class III-IV",
                        "criterion": "New York Heart Association class",
                        "requirement": {
                            "requirement_type": "class",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": ">=",
                                        "value": 3,
                                        "unit": "N/A"
                                    }
                                ]
                            }
                        }
                    },
                    {
                        "exact_snippets": "within 6 months prior to day 1 of protocol therapy",
                        "criterion": "time since cardiac event",
                        "requirement": {
                            "requirement_type": "time_window",
                            "expected_value": {
                                "comparisons": [
                                    {
                                        "operator": "<=",
                                        "value": 6,
                                        "unit": "months"
                                    }
                                ]
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "or_criteria": [
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Unstable or uncontrolled disease condition relating to or affecting cardiac function",
                                        "criterion": "cardiac disease condition",
                                        "requirement": {
                                            "requirement_type": "stability",
                                            "expected_value": false
                                        }
                                    },
                                    {
                                        "exact_snippets": "within 6 months prior to day 1 of protocol therapy",
                                        "criterion": "time since cardiac event",
                                        "requirement": {
                                            "requirement_type": "time_window",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 6,
                                                        "unit": "months"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "Unstable or uncontrolled disease condition relating to or affecting cardiac function",
                                        "criterion": "cardiac disease condition",
                                        "requirement": {
                                            "requirement_type": "control",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "within 6 months prior to day 1 of protocol therapy",
                                        "criterion": "time since cardiac event",
                                        "requirement": {
                                            "requirement_type": "time_window",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 6,
                                                        "unit": "months"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "unstable angina",
                                        "criterion": "unstable angina",
                                        "requirement": {
                                            "requirement_type": "presence",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "within 6 months prior to day 1 of protocol therapy",
                                        "criterion": "time since cardiac event",
                                        "requirement": {
                                            "requirement_type": "time_window",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 6,
                                                        "unit": "months"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "congestive heart failure",
                                        "criterion": "congestive heart failure",
                                        "requirement": {
                                            "requirement_type": "presence",
                                            "expected_value": true
                                        }
                                    },
                                    {
                                        "exact_snippets": "within 6 months prior to day 1 of protocol therapy",
                                        "criterion": "time since cardiac event",
                                        "requirement": {
                                            "requirement_type": "time_window",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 6,
                                                        "unit": "months"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            },
                            {
                                "and_criteria": [
                                    {
                                        "exact_snippets": "New York Heart Association Class III-IV",
                                        "criterion": "New York Heart Association class",
                                        "requirement": {
                                            "requirement_type": "class",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": ">=",
                                                        "value": 3,
                                                        "unit": "N/A"
                                                    }
                                                ]
                                            }
                                        }
                                    },
                                    {
                                        "exact_snippets": "within 6 months prior to day 1 of protocol therapy",
                                        "criterion": "time since cardiac event",
                                        "requirement": {
                                            "requirement_type": "time_window",
                                            "expected_value": {
                                                "comparisons": [
                                                    {
                                                        "operator": "<=",
                                                        "value": 6,
                                                        "unit": "months"
                                                    }
                                                ]
                                            }
                                        }
                                    }
                                ]
                            }
                        ]
                    }
                ]
            }
        },
        {
            "identified_line": {
                "line": "* Clinically significant medical disease or condition that, in the investigator's opinion, may interfere with protocol adherence or the patient's ability to give informed consent",
                "criterions": [
                    {
                        "exact_snippets": "Clinically significant medical disease or condition",
                        "criterion": "clinically significant medical disease or condition",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the investigator's opinion, may interfere with protocol adherence",
                        "criterion": "potential to interfere with protocol adherence",
                        "requirement": {
                            "requirement_type": "investigator judgment",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "in the investigator's opinion, may interfere with ... the patient's ability to give informed consent",
                        "criterion": "potential to interfere with ability to give informed consent",
                        "requirement": {
                            "requirement_type": "investigator judgment",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "and_criteria": [
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Clinically significant medical disease or condition",
                                "criterion": "clinically significant medical disease or condition",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "in the investigator's opinion, may interfere with protocol adherence",
                                "criterion": "potential to interfere with protocol adherence",
                                "requirement": {
                                    "requirement_type": "investigator judgment",
                                    "expected_value": true
                                }
                            }
                        ]
                    },
                    {
                        "and_criteria": [
                            {
                                "exact_snippets": "Clinically significant medical disease or condition",
                                "criterion": "clinically significant medical disease or condition",
                                "requirement": {
                                    "requirement_type": "presence",
                                    "expected_value": true
                                }
                            },
                            {
                                "exact_snippets": "in the investigator's opinion, may interfere with ... the patient's ability to give informed consent",
                                "criterion": "potential to interfere with ability to give informed consent",
                                "requirement": {
                                    "requirement_type": "investigator judgment",
                                    "expected_value": true
                                }
                            }
                        ]
                    }
                ]
            }
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "identified_line": {
                "line": "* Disease must be refractory or relapsed after >= 3 prior regimens (induction therapy and stem cell transplant +/- maintenance will be considered as one regimen)",
                "criterions": [
                    {
                        "exact_snippets": "Disease must be refractory or relapsed",
                        "criterion": "disease status",
                        "requirement": {
                            "requirement_type": "status",
                            "expected_value": [
                                "refractory",
                                "relapsed"
                            ]
                        }
                    },
                    {
                        "exact_snippets": ">= 3 prior regimens (induction therapy and stem cell transplant +/- maintenance will be considered as one regimen)",
                        "criterion": "number of prior regimens",
                        "requirement": {
                            "requirement_type": "count",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "regimens"
                            }
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Agreement by woman of childbearing potential and sexually active males to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation",
                "criterions": [
                    {
                        "exact_snippets": "Agreement by woman of childbearing potential ... to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation",
                        "criterion": "contraception use by women of childbearing potential",
                        "requirement": {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Agreement by woman of childbearing potential ... to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation",
                        "criterion": "contraception use by women of childbearing potential",
                        "requirement": {
                            "requirement_type": "contraception method",
                            "expected_value": [
                                "hormonal",
                                "barrier method of birth control",
                                "abstinence"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Agreement by woman of childbearing potential ... to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation",
                        "criterion": "contraception use by women of childbearing potential",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "prior to study entry and for three months following duration of study participation"
                        }
                    },
                    {
                        "exact_snippets": "Agreement by ... sexually active males to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation",
                        "criterion": "contraception use by sexually active males",
                        "requirement": {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Agreement by ... sexually active males to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation",
                        "criterion": "contraception use by sexually active males",
                        "requirement": {
                            "requirement_type": "contraception method",
                            "expected_value": [
                                "hormonal",
                                "barrier method of birth control",
                                "abstinence"
                            ]
                        }
                    },
                    {
                        "exact_snippets": "Agreement by ... sexually active males to use an effective method of contraception (hormonal or barrier method of birth control or abstinence) prior to study entry and for three months following duration of study participation",
                        "criterion": "contraception use by sexually active males",
                        "requirement": {
                            "requirement_type": "timing",
                            "expected_value": "prior to study entry and for three months following duration of study participation"
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "FOR PATIENTS WITH MM OR CLL:",
                "criterions": [
                    {
                        "exact_snippets": "FOR PATIENTS WITH MM OR CLL",
                        "criterion": "diagnosis",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": [
                                "multiple myeloma",
                                "chronic lymphocytic leukemia"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "- At least 2 weeks from prior therapy to time of start of treatment; prior therapy includes steroids (except for =< 10 mg daily prednisone or equivalent which is permitted during the study)",
                "criterions": [
                    {
                        "exact_snippets": "At least 2 weeks from prior therapy to time of start of treatment",
                        "criterion": "interval since prior therapy",
                        "requirement": {
                            "requirement_type": "minimum duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "weeks"
                            }
                        }
                    },
                    {
                        "exact_snippets": "prior therapy includes steroids (except for =< 10 mg daily prednisone or equivalent which is permitted during the study)",
                        "criterion": "steroid use",
                        "requirement": {
                            "requirement_type": "maximum daily dose",
                            "expected_value": {
                                "operator": "<=",
                                "value": 10,
                                "unit": "mg"
                            }
                        }
                    },
                    {
                        "exact_snippets": "prior therapy includes steroids (except for =< 10 mg daily prednisone or equivalent which is permitted during the study)",
                        "criterion": "steroid use",
                        "requirement": {
                            "requirement_type": "steroid type",
                            "expected_value": [
                                "prednisone",
                                "prednisone equivalent"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Total bilirubin =< 1.5 x ULN; unless presence of Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment",
                "criterions": [
                    {
                        "exact_snippets": "Total bilirubin =< 1.5 x ULN; unless presence of Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": "<=",
                                "value": 1.5,
                                "unit": "x ULN"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Total bilirubin =< 1.5 x ULN; unless presence of Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment",
                        "criterion": "total bilirubin",
                        "requirement": {
                            "requirement_type": "exception",
                            "expected_value": [
                                "presence of Gilbert's syndrome",
                                "liver involvement by CLL or MM",
                                "stable chronic liver disease per investigator's assessment"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Measurable lymph nodes > 1.5 cm on palpation and/or computed tomography (CT) scan",
                "criterions": [
                    {
                        "exact_snippets": "Measurable lymph nodes > 1.5 cm on palpation and/or computed tomography (CT) scan",
                        "criterion": "lymph nodes",
                        "requirement": {
                            "requirement_type": "measurability",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Measurable lymph nodes > 1.5 cm on palpation and/or computed tomography (CT) scan",
                        "criterion": "lymph nodes",
                        "requirement": {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">",
                                "value": 1.5,
                                "unit": "cm"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Measurable lymph nodes > 1.5 cm on palpation and/or computed tomography (CT) scan",
                        "criterion": "lymph nodes",
                        "requirement": {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "palpation",
                                "computed tomography (CT) scan"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Organomegaly by physical exam and/or CT scan",
                "criterions": [
                    {
                        "exact_snippets": "Organomegaly by physical exam and/or CT scan",
                        "criterion": "organomegaly",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "Organomegaly by physical exam and/or CT scan",
                        "criterion": "organomegaly",
                        "requirement": {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "physical exam",
                                "CT scan"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Creatinine clearance of >= 45 mL/min per 24 hour urine collection or the Cockcroft-Gault formula",
                "criterions": [
                    {
                        "exact_snippets": "Creatinine clearance of >= 45 mL/min per 24 hour urine collection or the Cockcroft-Gault formula",
                        "criterion": "creatinine clearance",
                        "requirement": {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 45,
                                "unit": "mL/min"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Creatinine clearance of >= 45 mL/min per 24 hour urine collection or the Cockcroft-Gault formula",
                        "criterion": "creatinine clearance",
                        "requirement": {
                            "requirement_type": "measurement_method",
                            "expected_value": [
                                "24 hour urine collection",
                                "Cockcroft-Gault formula"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        },
        {
            "identified_line": {
                "line": "* Massive (i.e., at least 6 cm below the left costal margin) or progressive or symptomatic splenomegaly",
                "criterions": [
                    {
                        "exact_snippets": "Massive (i.e., at least 6 cm below the left costal margin) ... splenomegaly",
                        "criterion": "splenomegaly",
                        "requirement": {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "cm below the left costal margin"
                            }
                        }
                    },
                    {
                        "exact_snippets": "Massive (i.e., at least 6 cm below the left costal margin) ... splenomegaly",
                        "criterion": "splenomegaly",
                        "requirement": {
                            "requirement_type": "severity",
                            "expected_value": "massive"
                        }
                    },
                    {
                        "exact_snippets": "progressive ... splenomegaly",
                        "criterion": "splenomegaly",
                        "requirement": {
                            "requirement_type": "progression",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "symptomatic splenomegaly",
                        "criterion": "splenomegaly",
                        "requirement": {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    }
                ]
            },
            "logical_structure": {
                "or_criteria": [
                    {
                        "exact_snippets": "Massive (i.e., at least 6 cm below the left costal margin) ... splenomegaly",
                        "criterion": "splenomegaly",
                        "requirement": {
                            "requirement_type": "size",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "cm below the left costal margin"
                            }
                        }
                    },
                    {
                        "exact_snippets": "progressive ... splenomegaly",
                        "criterion": "splenomegaly",
                        "requirement": {
                            "requirement_type": "progression",
                            "expected_value": true
                        }
                    },
                    {
                        "exact_snippets": "symptomatic splenomegaly",
                        "criterion": "splenomegaly",
                        "requirement": {
                            "requirement_type": "symptomatic",
                            "expected_value": true
                        }
                    }
                ]
            }
        }
    ],
    "failed_exclusion": [
        {
            "identified_line": {
                "line": "* Liver disease, except Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment",
                "criterions": [
                    {
                        "exact_snippets": "Liver disease, except Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment",
                        "criterion": "liver disease",
                        "requirement": {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    },
                    {
                        "exact_snippets": "Liver disease, except Gilbert's syndrome, liver involvement by CLL or MM, or stable chronic liver disease per investigator's assessment",
                        "criterion": "liver disease",
                        "requirement": {
                            "requirement_type": "exceptions",
                            "expected_value": [
                                "Gilbert's syndrome",
                                "liver involvement by CLL or MM",
                                "stable chronic liver disease per investigator's assessment"
                            ]
                        }
                    }
                ]
            },
            "logical_structure": {
                "exact_snippets": "failed",
                "criterion": "failed",
                "requirement": {
                    "requirement_type": "failed",
                    "expected_value": "failed"
                }
            }
        }
    ],
    "failed_miscellaneous": []
}